The Lutheran (LU) glycoprotein was shown to be a specific marker of brain capillary endothelium, which forms the blood-brain barrier (BBB) in vivo. A 1.5 kb partial cDNA encoding the bovine LU was isolated from a bovine brain cap illary cDNA library. Sequence analysis showed that the bovine and human LU had a 75% and 79% identity in the amino acid and nucleotide sequences, respectively. Northern blot analysis demonstrated a very high level of gene expression of the LU transcript in freshly isolated bovine brain capillaries, but no measurable LU mRNA in whole bovine brain. The high level of LU gene expression was maintained when bovine brain capil lary endothelium was grown in tissue culture. Because many BBB specific genes are downregulated in tissue culture and in brain tumors, the expression of the LU mRNA and immuno-
The Lutheran (LV) glycoprotein is an 85 kDa glyco protein that was originally detected in human erythro cytes and subsequently shown to be a basolateral antigen in diverse epithelial cells (Parsons et aI., 1995) . The LU glycoprotein is related to the human basal cell adhesion molecule (B-CAM), which is a cell surface glycoprotein of epithelial cancers (Campbell et al., 1994) . The LU glycoprotein and the B-CAM protein arise from mRNA molecules that are spliceoforms of the same transcript (Rahuel et aI., 1996) . The B-CAM protein has a trun cated carboxyl terminus and is translated from a 4.0 kb transcript, whereas the LV mRNA is 2.5 kb. Northern tissue surveys have demonstrated the presence of the 2.5 kb LV transcript, but not 4.0 kb B-CAM mRNA, in human brain (Rahuel et aI., 1996) .
active LU protein was investigated in primary and metastatic human brain tumors. Immunocytochemistry of fresh frozen hu man brain and human brain tumors showed abundant immu nostaining of brain capillary endothelium. Northern blot analy sis showed the presence of LU transcripts in a panel of primary and metastatic human brain tumors. These studies demon strated that the LU glycoprotein was a novel new marker of the BBB, and unlike other BBB specific genes, there was a per sistent gene expression of the LU glycoprotein both in brain capillary endothelial cells grown in culture and in the endothe lium of capillaries perfusing human brain cancer. Key Words:
Blood-brain barrier-Lutheran glycoprotein-Brain tumors Endothelium.
The cellular origin of the LU glycoprotein in brain is not known. Apart from the choroid plexus epithelium, the other cell in brain that has epithelial-like character istics is the capillary endothelium, which forms the blood-brain barrier (BBB) in vivo. Like epithelial barri ers in peripheral tissues, the capillary endothelia in ver tebrate brain are fused together by epithelial-like, high resistance, tight junctions to form the BBB in vivo (Par dridge and . The current studies report that a partial cDNA of the bovine homologue of the LV gly coprotein was, in fact, identified in screening a bovine brain capillary cDNA library. The current studies de scribed the cloning and sequencing of this partial cDNA and the high degree of homology to the human LV gly coprotein. Bovine LV cDNA was used in Northern blot ting to demonstrate the selective expression of the LV gene in brain at the capillary endothelium. Unlike many BBB specific genes, which are downregulated in tissue culture (Black et aI., 1990) , the high LV gene expression at the BBB persisted in cultured brain capil lary endothelium. Because many BBB specific genes are also downregulated in capillaries of brain tumors (Black et aI., 1990; Guerin et aI., 1990 Guerin et aI., , 1992 , the current stud-ies examined the expression of the LU mRNA and pro tein in human brain tumors. Lutheran gene expression was identified in primary brain tumors, and immunocy tochemistry showed that the LU protein was selectively expressed at the tumor capillary endothelium. These re sults indicated that the LU glycoprotein was a novel marker of brain capillary endothelia, which form the BBB in vivo, and that the high LU gene expression at the BBB persists in cell culture and in primary brain tumors. . Total and size-fractionated bovine brain microvessels cDNA libraries were prepared in Agtll and pSPORT vectors, respectively, and characterized as previously reported in this laboratory (Boado and Pardridge, 1990; Boado et a!., 1999) . Human primary and metastatic brain tumors were obtained fresh frozen from the UCLA Department of Surgery/Neurosurgery and Department of Pathology/Neuropathology as described previously (Boado et a!., 1992) . C6 rat glioma cells were obtained from the Ameri can Type Culture Collection (Rockville, MD, U.S.A.). BcI-IO cells, or ECL cells, are a line of bovine brain capillary endo thelial cells described previously .
MATERIALS AND METHODS

Isolation of bovine LU cDNA
A partial cDNA encoding the bovine LU glycoprotein was identified in the process of isolating eDNA for the bovine large neutral amino acid transporter type I (LA Tl), as described recently (Boado et a!., 1999) . The bovine LAT and the LU cDNA were isolated from a bovine brain capillary Agtll eDNA library, which has been characterized in previous studies (Boado and Pardridge, 1990) . Approximately 2.2 x 105 recom binants of this library were screened with the 32p_ clone LAT 1-6, which was a pCR2.1 plasmid encoding an approximate 0.2 kb fragment produced by the polymerase chain reaction and corresponding to a fragment of the rat LA T 1. This screening produced a clone that released a 2.0 kb eDNA, which was subcloned in the Bluescript plasmid and named LAT IV-S (Boado et a!., 1999) . DNA sequencing analysis of this clone revealed that it was composed of the bovine BBB LAT I eDNA (accession # AF17461S, nt 838-2244) artifactually fused to a partial cDNA that was 86% similar to nt IS20-1797 of the human LU (accession # X8342S). Restriction endonuclease analysis revealed that a single BstXI site separated the LU and LATI cDNA in addition to the BstXI site in the multiple clon ing region of the plasmid. Therefore, the 200 bp LU fragment was released by BstXI and the -200 bp BstXI LU 32p_cDNA was used for screening of a size-fractionated bovine brain mi crovessel eDNA library in the pSPORT vector, which has been characterized previously (Boado et a!., 1999) . After screening of 2.4 x 105 recombinants, 37 clones were positive for bovine LU, and 4 of them were isolated for further characterization. 
DNA sequencing
DNA sequencing of isolated clones was performed in both directions at the Keck Biotech Resource Laboratory (DNA Se quencing Core Facility, Yale University, CT, U.S.A.) and at the Biotech Core (Palo Alto, CA, U.S.A.), and confirmed by manual DNA sequencing as described previously (Boado et a!., 1999) . Similarities with related cDNA deposited in GenBank were investigated using the BLAST program (NCBI, NIH), and the phylogenetic analysis of the LAT sequence was performed with the LALIGN program available through the FASTA pack age at the University of Virginia (Pearson and Lipman, 1988) .
Isolation of poly A+ RNA and Northern blot analysis
Poly A+ RNA was isolated from bovine brain capillaries, rat organs, cultured bovine brain capillary endothelium, C6 rat glioma cells, and primary and metastatic human brain tumors using a single step method previously described (Boado and Pardridge, 1991) ; 2 to 10 t-Lg of poly A+ RNA were resolved in I.S% agarose:2.2 mollL formaldehyde gels, and blotted onto GeneScreen Plus membranes. Northern blots were hybridized with [32Pl-Iabeled LU or (3-actin cDNA probes as described previously (Boado et aI., 1999) . cDNA were labeled with e2Pl dCTP by the random priming technique using the Megaprimer DNA labeling kit (Boado and Pardridge, 1991) . Blots were quantified by optical scanning densitometry of autoradiograms using the National Institutes of Health Image I.S4 program on a Power Macintosh 7100/66 AV microcomputer (Boado et a!., 1999) .
Immunocytochemistry
Immunocytochemical detection of LU was performed in 10t-Lm frozen sections of normal human brain and human glio blastoma mutiforme using the avidin-peroxidase method of immunocytochemistry (Hsu et a!., 1981) . Sections were fixed with 100% methanol (20 minutes, -20°C), washed with ice cold PBS, and air-dried. Samples were incubated with anti-LU hybridoma conditioned medium or mouse IgG control (It-Lg/ mL), and the immune reacti' on was developed using biotinyl ated horse anti-mouse IgG (Vector Labs, Burlingame, CA, U.S.A.) and the ABC Elite kit (Vector Labs) (Hsu et a!., 1981) .
Slides were counterstained with Mayer's hematoxylin. The an tihuman LU hybridoma (LM3421767) conditioned media was kindly provided by Dr. Robin Fraser of the Glasgow and West Scotland Blood Transfusion Service (Lanarkshire, Scotland); this antibody recognizes the first immunoglobulin superfamily domain of the LU glycoprotein (Zen et aI., 1999) .
RESULTS
The nucleotide and predicted amino acid sequence of the partial bovine LU cDNA are shown in Fig. 1 . The 1540 nucleotide cDNA encodes the entire 3' untranslated region including a 36-mer poly A tail pre ceded by an ATAAA polyadenylation consensus site. The partial cDNA begins at Gln 243 which corresponds to the pro 243 in the human LU glycoprotein (Parsons et aI., 1995) . There was a single 20 amino acid transmembrane R.l. BOADO ET AL.
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region near the carboxyl terminus of the LU glycopro tein, and this region was highly conserved between hu man and bovine with only two conservative substitu tions. There was a 75% identity in the amino acid se quence of the bovine and human LU protein. There was a 79% identity between the corresponding human and bovine LU nucleotide sequence and an 85% nucleotide identity over the 378 nucleotides comprising the 3' untranslated region. Northern blot analysis with the bovine LU cDNA showed that the LU mRNA was highly abundant in freshly isolated bovine brain capillaries, as the 2.5 kb bovine BBB LU mRNA was detected after a 16-hour exposure of the x-ray film (Fig. 2A, lane 1) . In contrast, no LU transcript was detected in total bovine brain after this exposure ( Fig. 2A, lane 2) . High levels of gene ex pression of the LU transcript in bovine brain capillary endothelial cells persisted in cell culture as shown by the Northern blot in Fig. 2B , which was exposed at room temperature for only 4 hours. In contrast to the BBB in vivo ( Fig. 2A) , the cultured bovine brain capillary endo thelial cells produced 2 LU transcripts of 3.2 and 2.5 kb (Fig. 2B) . The LU gene expression in C6 rat glioma cells was negligible because no measurable LU transcript was detected after a 9-day exposure of the Northern blot at -70°C (Fig. 2B) . The bovine LU cDNA cross-hybridized with rat LU transcript as Northern blotting of 2 j-Lg per lane of poly A+ RNA from rat organs demonstrated ex pression of the LU gene in rat lung (Fig. 2C) . When larger amounts of the rat organ RNA were analyzed (10 j-Lg poly A+ RNA per lane), it was possible to visualize the rat LU transcript in rat heart and skeletal muscle, in FIG. 2. (A) Northern blot analysis of freshly isolated bovine brain capillar ies (lane 1) and whole bovine brain (lane 2); 2 �g of polyA + mRNA was applied per lane, and after Northern blotting the filter was exposed to the x-ray film for 16 hours at -70°C. (8)
Northern blotting of triplicate samples of either bovine brain capillary endo thelial cells grown in tissue culture (BCI-10 cells) or C6 rat glioma cells. The BCI-10 filter was exposed to the x-ray film for 4 hours at room tem perature, and the C6 rat glioma cell filter was exposed to the x-ray film for 9 days at -70°C; 3 �g of polyA+ mRNA was applied per lane. (e) Northern blot analysis of rat tissues: heart, kidney, lung, and liver (lanes 1 to 4, respectively); 2 �g of poly-A+ mRNA was applied per lane, and the filter was exposed to x-ray film for 9 days at -70°C. (D) Northern blot of rat organ poly A+ RNA. The x-ray film was exposed to the filter for 9 days at -70°C, and 10 �g poly A+ RNA was applied per lane. RNA samples from four different rats are shown for each organ.
A 12 2.5 kbbrain D 2.5 kb--addition to rat lung. No LU transcript was detected in rat brain, spleen, or testes (Fig. 2D) . A smaller sized tran script, 1.4 kb, was found in lung, heart, and skeletal muscle (Fig. 2D) .
The Northern blotting results indicated that the LU glycoprotein gene expression in brain was restricted to the BBB. This was confirmed by immunocytochemistry using a monoclonal antibody to the human LU glycopro tein. The studies with control human brain are shown in Fig. 3 . No detectable immunoreactive LU glycoprotein was observed in brain parenchyma. In contrast, abundant immunoreactive LU glycoprotein was detected at the brain microvasculature and the continuous immune staining of the microvessels indicated an endothelial ori gin of the immunoreactive LU glycoprotein in human brain.
Because the LU glycoprotein gene expression was maintained at a high level in brain capillary endothelial cells grown in tissue culture (Fig. 2B) , it was hypoth esized that there might be persistent gene expression in capillaries perfusing human brain tumors. This hypoth esis was confirmed by both Northern blot analysis and immunocytochemistry as shown in Fig. 4 . The 2.5 and 1.4 kb LU transcripts were detected in gliomas, menin giomas, and metastatic tumors to the brain (Fig. 4B) . Immunostaining of frozen sections of human glioblas toma multi forme demonstrated immunoreactive LU gly coprotein in tumor capillaries ( Fig. 4A ).
DISCUSSION
The results of these studies agreed with the following conclusions. First, the LU glycoprotein is expressed at the bovine and human BBB in normal brain, similar to epithelial barriers in peripheral tissues. Second, unlike many BBB specific gene products (Black et aI., 1990; Guerin et aI., 1990 Guerin et aI., , 1992 Pardridge and Boado, 1993) , there is no downregulation of the LU glycoprotein gene in brain capillary endothelium grown in tissue culture (Fig. 2) . Third, there is persistent gene expression of the LU glycoprotein at the human BBB perfusing both pri mary and metastatic human brain tumors (Fig. 4) . The high level of gene expression of the LU glyco protein at the BBB was demonstrated in normal human brain by immunocytochemistry ( Fig. 3) and in control bovine brain by Northern blot analysis (Fig. 2) . How ever, there was no detectable LU mRNA in whole bovine brain ( Fig. 2A) , or in C6 rat glioma cells even after prolonged exposure of the filter to x-ray film (Fig. 2B) . The copy number of the LU glycoprotein mRNA at the BBB was extremely high as the transcript was detected with only a 16-hour exposure of the x-ray film using 2 I-Lg of poly A+ mRNA per lane ( Fig. 2A) . Therefore, the copy number of the LU mRNA is nearly comparable to that of the LATl mRNA at the bovine BBB (Boado et J Cereb Blood Flow Me/ab. Vol. 20. No. 7, 2000 aI., 1999), but is much greater than the abundance of the Gluti glucose transporter mRNA at the BBB . There is a downregulation of many BBB specific genes when brain capillary endothelial cells are grown in cell culture (Black et aI., 1990; Guerin et aI., 1990 Guerin et aI., , 1992 Pardridge and Boado, 1993) , For ex ample, there is a 100-fold downregulation in Gluti glu cose transporter mRNA in bovine brain capillary endo thelial cells grown in cell culture relative to freshly iso lated bovine brain capillaries Pardridge, 1990, 1993) . In contrast, there was no downregulation of the LU glycoprotein mRNA when bovine brain capillary cells were grown in cell culture as shown by the Northern blotting studies in Fig. 2B , There was differential pro cessing of the LU glycoprotein mRNA in cell culture as there was a doublet 3.212.5 kb LU glycoprotein transcript in bovine brain capillary endothelial cells grown in tissue culture (Fig. 2B) . The 3.2 kb LU mRNA had not been reported previously and might be the product of differ ential mRNA processing in cultured cells.
The persistent expression of the LU glycoprotein gene in brain capillary endothelial cells grown in tissue culture paralleled the persistent high level of expression of this gene at the BBB in human brain tumors (Fig. 4) . The anti-LU antibody illuminated capillaries in human high grade gliomas (Fig. 4A ), similar to normal human brain (Fig. 3) . These immunocytochemistry results were the first demonstration of LU glycoprotein expression at the microvascular endothelium. Previous studies have re ported the expression of immunoreactive LU glycopro tein in the arterial walls of human liver, kidney, and placenta (Parsons et aI., 1995) . Northern blotting showed 2.5 kb and 1.4 kb LU transcripts in primary and meta static brain tumors (Fig. 4B) . The smaller 1.4 kb LU mRNA was also observed in rat lung, heart, and skeletal muscle (Fig. 2D) . The 1.4 kb LU mRNA has not been reported previously (Campbell et aI., 1994; Rahuel et aI., 1996) , and t he str u cture and function of this truncated transcript is not known. The relatively low level of LU glycoprotein mRNA in high grade gliomas was likely because this gene was expressed only at the tumor mi crovasculature (Fig. 4A ) and the dilution of the tumor microvascular-derived LU mRNA in the whole tumor extract used to prepare the mRNA samples (Fig. 4B) .
Many BBB specific gene products that are downregu lated in cell culture are also down regulated in capillaries perfusing human brain tumors (Black et aI., 1990; Guerin et aI., 1990 Guerin et aI., , 1992 . The persistent high gene expression of the LU glycoprotein at the BBB in either cell culture or human brain tumors might relate to the functional significance of this gene product at the BBB. The LU glycoprotein appeared to be an important cell adhesion molecule that might function in pathophysiologic states. The LU glycoprotein in erythrocytes from patients with sickle cell anemia is a receptor for the laminin protein 1 and 2) , meningioma (lanes 3 to 5), oligodendrioma (lane 6), glioblastoma multiforme (lane 7), adeno carcinoma metastatic to brain (lane 8), renal carcinoma metastatic to brain (lane 9), and malignant melanoma metastatic to brain (lane 10). The blot was exposed to x-ray film for 10 days at -70DC. The actin blot for each corresponding tumor is shown in the bottom panel (Boado et aI. , 1992) . (Nemer et aI., 1998; Vdani et aI., 1998) . Laminin consti tutes a significant part of the brain microvascular extra cellular matrix and basement membrane (Sobel et aI., 1998) . Whether the BBB LV glycoprotein is a laminin receptor under normal or pathophysiologic conditions is not known at the present time. The persistent expression of the LV gene in brain tumor capillaries may enable tumor capillary endothelium to adhere to basement mem brane components such as laminin, and enable angiogen esis. Recent studies have demonstrated that the Leu sn _ Leu s78 motif directs the LV glycoprotein to the basolat eral membrane in cultured epithelium (Nemer et aI., 1999) . The selective localization of the LV glycoprotein to the antiluminal membrane of the brain capillary en dothelium, which is the functional equivalent of the ep ithelial basolateral membrane, would enable LV binding to components of the extracellular matrix such as laminin.
There was a high degree of structural similarity be tween the nucleotide and amino acid sequence of the bovine and human LV glycoprotein (Fig. 1 ). All 10 of the cysteine residues in the bovine LV sequence, begin ning with residue 243, were 100% conserved compared with the human sequence, including the carboxyl termi-nal cysteine residue. The single transmembrane region of this glycoprotein was strongly conserved with only 2 conservative substitutions between the human and bo vine sequences (Parsons et aI., 1995, Fig. 1 ). Between amino acid Gln 243 and the transmembrane region, there were several consensus sequences for N-linked glyco sylation in the human an d bovine LV (Fig. 1) . The Pro SS7 residue, which forms the carboxyl terminus of the B CAM isoform was also conserved, as was the src homol ogy 3 (SH3) region between the Pro SS7 and pro S62 (Par sons et aI., 1995).
In summary, these studies demonstrated that the LV glycoprotein was a novel new marker of BBB function in normal and pathophysiologic states such as brain tumors. The LV glycoprotein might be a preferred BBB marker owing to the high level of gene expression of the LV glycoprotein at the BBB and owing to the persistent ex pression of the LV glycoprotein gene at the BBB in cell culture and in human brain tumors (Fig. 4) .
